John Wallbillich
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 10
- Cytokine Signaling Pathways and Interactions 3
-
- MicroRNA in disease regulation 4
- Cancer Genomics and Diagnostics 3
- Co-authors
- David E. Cohn (10 shared papers)Karuppaiyah Selvendiran (5 shared papers)Kalpana Deepa Priya Dorayappan (6 shared papers)Adrian A. Suarez (6 shared papers)Ross Wanner (6 shared papers)Uksha Saini (3 shared papers)Roman A. Zingarelli (5 shared papers)Michael Frumovitz (3 shared papers)
- Journals
- Gynecologic Oncology (19 papers)Oncogene (3 papers)Journal of Clinical Oncology (2 papers)Cancer Medicine (1 paper)Oncotarget (1 paper)
- Partner nations
- United StatesItalyHungary
In The Last Decade
John Wallbillich
28 papers receiving 671 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 259
- Reproductive Medicine 65
- Obstetrics and Gynecology 45
- Molecular Biology 365
- Oncology 127
Countries citing papers authored by John Wallbillich
This map shows the geographic impact of John Wallbillich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wallbillich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wallbillich more than expected).
Fields of papers citing papers by John Wallbillich
This network shows the impact of papers produced by John Wallbillich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wallbillich. The network helps show where John Wallbillich may publish in the future.
Co-authors
The 25 scholars most cited alongside John Wallbillich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 252 | |
| 2 | 2016 | 97 | |
| 3 | 2016 | 73 | |
| 4 | 2012 | 66 | |
| 5 | 2017 | 30 | |
| 6 | 2013 | 28 | |
| 7 | 2018 | 18 | |
| 8 | 2020 | 17 | |
| 9 | 2016 | 15 | |
| 10 | 2012 | 13 | |
| 11 | 2020 | 9 | |
| 12 | Identification of a transcriptomic signature with excellent survival prediction for squamous cell carcinoma of the cervix. | 2020 | 9 |
| 13 | 2020 | 8 | |
| 14 | 2023 | 7 | |
| 15 | 2024 | 6 | |
| 16 | 2024 | 4 | |
| 17 | 2020 | 4 | |
| 18 | 2012 | 4 | |
| 19 | 2018 | 3 | |
| 20 | 2017 | 2 |
About John Wallbillich
John Wallbillich is a scholar working on Oncology, Cancer Research, Molecular Biology, Epidemiology and Obstetrics and Gynecology, having authored 30 papers that have together received 676 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (5 papers), Endometrial and Cervical Cancer Treatments (4 papers), MicroRNA in disease regulation (4 papers), Cancer Genomics and Diagnostics (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Cervical Cancer and HPV Research (3 papers), Economic and Financial Impacts of Cancer (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Cancer Research (259 citations), Reproductive Medicine (65 citations), Obstetrics and Gynecology (45 citations), Molecular Biology (365 citations) and Oncology (127 citations). John Wallbillich has collaborated with scholars based in United States, Italy and Hungary. Frequent co-authors include David E. Cohn, Karuppaiyah Selvendiran, Kalpana Deepa Priya Dorayappan, Adrian A. Suarez, Ross Wanner, Uksha Saini, Roman A. Zingarelli, Michael Frumovitz, J. Quincy Brown and Kristin Bixel. Their work appears in journals such as Gynecologic Oncology, Oncogene, Journal of Clinical Oncology, Cancer Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.